Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $458,632 | $2.3M | $2.1M | $2.8M | $1.1M | $803,840 |
| Gross profit | $372,657 | $1.6M | $1.2M | $1.7M | $646,901 | $188,873 |
| Gross margin | 81.25% | 70.99% | 55.35% | 62.55% | 61.56% | 23.50% |
| Research & development | — | — | — | — | $75,062 | — |
| Operating expenses | $2.6M | $3.8M | $2.2M | $2.2M | $2.2M | $869,921 |
| Operating income | −$2.2M | −$2.1M | −$1.1M | −$498,389 | −$1.6M | −$681,048 |
| Operating margin | −490.50% | −92.04% | −49.59% | −17.98% | −149.81% | −84.72% |
| EBITDA | −$2.2M | −$2.0M | −$956,546 | −$473,982 | — | — |
| EBITDA margin | −490.02% | −85.96% | −44.98% | −17.10% | — | — |
| Net income | −$2.3M | −$2.1M | −$1.1M | −$541,453 | −$1.6M | −$721,290 |
| Net profit margin | −498.01% | −92.11% | −49.77% | −19.54% | −150.59% | −89.73% |
| Basic EPSper basic share | -$0.02 | -$0.02 | -$0.01 | $0.00 | -$0.02 | -$0.01 |
| Diluted EPSper diluted share | -$0.02 | -$0.02 | -$0.01 | $0.00 | -$0.02 | -$0.01 |
Reported shareholders